Inventor · disambiguated record
Eckhard Bender
Also filed as: BENDER ECKHARD
10 granted patents·19 pending applications·34 citations·filing 2000–2016
84Inventor score
Files withBayer Pharma AG10HEIMBACH DIRK9JANSSEN PHARMACEUTICA NV3BAYER IP GMBH2BAYER PHARMA AKTIENGESELLSHAFT1
Top patents by PatentIndex Score
29 records- 0188US8119663B2Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2008·Granted Feb 21, 2012·16 cites·8 claims
- 0283US8084481B2Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsMEIER HEINRICH·Filed 2007·Granted Dec 27, 2011·11 cites·11 claims
- 0374US8987248B2Substituted piperidines as Par-1 antagonistsJESKE MARIO·Filed 2010·Granted Mar 24, 2015·1 cites·9 claims
- 0474US8084469B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted Dec 27, 2011·3 cites·17 claims
- 0572US8202862B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted Jun 19, 2012·2 cites·27 claims
- 0654US2013252948A1Substituted piperidinesBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 0753US6998244B1Cloning and expression of a novel 5-HT4 receptorJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Feb 14, 2006·1 cites·14 claims
- 0850US2015183773A1Substituted piperidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 0949US8440657B2Substituted piperidinesHEIMBACH DIRK·Filed 2010·Granted May 14, 2013·0 cites·23 claims
- 1046US2013005704A1Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsBAYER PHARMA AKTIENGESELLSHAFT·Filed 2011·Application pending·0 cites
- 1145US2012214788A1Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2012·Application pending·0 cites
- 1244US2007087388A1G protein coupled receptorJANSSEN PHARMACEUTICA NV·Filed 2006·Application pending·0 cites
- 1343US7402563B2EPF derived peptides and therapeutic compositionsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jul 22, 2008·0 cites·5 claims
- 1442US10130633B2CompoundsBayer Pharma AG·Filed 2014·Granted Nov 20, 2018·0 cites·17 claims
- 1542US2016052898A1Novel compoundsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1641US2012220563A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 1740US2018148418A1Amido-substituted cyclohexane derivativesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1840US2014357655A1Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonistsBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 1935US2003157516A1G protein coupled receptorFiled 2001·Application pending·0 cites
- 2035US2012149694A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 2135US2012129831A1Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-PhenylpiperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 2234US2004235722A1Epf receptor assays, compounds and therapeutic compositionsFiled 2002·Application pending·0 cites
- 2333US2012142690A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 2433US2018044306A11,3,4-thiadiazol-2-yl-benzamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2533US2018042931A1N-phenyl-(morpholin-4-yl or piperazinyl)acetamide derivatives and their use as inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2633US2018028507A13-carbamoylphenyl-4-carboxamide and isophtalamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2731US2017107212A1Novel compoundsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2831US2017114070A1Inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2930US9884063B2Amido-substituted azole compoundsBayer Pharma AG·Filed 2015·Granted Feb 6, 2018·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →